Free shipping on all orders over $ 500

Kenpaullone

Cat. No. M3774

All AbMole products are for research use only, cannot be used for human consumption.

Kenpaullone Structure
Synonym:

NSC-664704, 9-Bromopaullone, 9-Bromo-7

Size Price Availability Quantity
1mg USD 35 In stock
5mg USD 64 In stock
10mg USD 98 In stock
25mg USD 196 In stock
50mg USD 332 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Kenpaullone represents a novel chemotype for compounds that preferentially inhibit CDKs. Kenpaullone inhibits CDK2/cyclin A, CDK2/cyclin E and CDK5/cyclin/p35 (IC50 values are 0.68, 7.5 and 0.85 μM respectively). Kenpaullone is selective over c-src (IC50 = 15 μM), casein kinase 2 (IC50 = 20 μM), ERK1 (IC50 = 20 μM), ERK2 (IC50 = 9 μM) and a range of other protein kinases (IC50 values > 35 μM). Kenpaullone generates induced pluripotent stem cells (iPSCs) from somatic cells when used in combination with reprogramming factors. Kenpaullone can take the place of Klf4.

Protocol (for reference only)
Cell Experiment
Cell lines HEK-293 cells
Preparation method
Concentrations 10μM
Incubation time 0-12h
Animal Experiment
Animal models
Formulation
Dosages
Administration
Chemical Information
Molecular Weight 327.18
Formula C16H11BrN2O
CAS Number 142273-20-9
Solubility (25°C) DMSO 18 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Lyssiotis CA, et al. Proc Natl Acad Sci U S A. Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4.v

[2] Buolamwini JK. Curr Pharm Des. Cell cycle molecular targets in novel anticancer drug discovery.

[3] Schultz C, et al. J Med Chem. Paullones, a series of cyclin-dependent kinase inhibitors: synthesis, evaluation of CDK1/cyclin B inhibition, and in vitro antitumor activity.

[4] Zaharevitz DW, et al. Cancer Res. Discovery and initial characterization of the paullones, a novel class of small-molecule inhibitors of cyclin-dependent kinases.

Related CDK Products
AT7519

AT7519 is a novel small molecule multi-cyclin-dependent (CDK) kinase inhibitor.

Flavopiridol

Flavopiridol (Alvocidib) is a competitive broad-spectrum CDK inhibitor with IC50 of 30,170,100 nM against CDK1, CDK2 and CDK4, respectively.

R547

R547 is a potent and selective ATP-competitive CDK inhibitor, with Ki values of 2 nM, 3 nM and 1 nM for CDK1/cyclin B, CDK2/cyclin E and CDK4/cyclin D1, respectively.

JNJ-7706621

JNJ-7706621 is a dual cell cycle inhibitor with activity against cyclin-dependent kinases (CDK1, 2, 3, 6) with an IC50 of 3-175 nM and Aurora kinases (A and B) with an IC50 of 11-15 nM respectively.

PD 0332991 HCL

PD-0332991 HCl is a highly selective inhibitor of CDK4/6 with IC50 of 11 nM/16 nM in cell-free assays, respectively. It shows no activity against CDK1/2/5, EGFR, FGFR, PDGFR, InsR, etc.

  Catalog
Abmole Inhibitor Catalog




Keywords: Kenpaullone, NSC-664704, 9-Bromopaullone, 9-Bromo-7 supplier, CDK, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.